Data / Form D filings / Quest PharmaTech Inc.
Quest PharmaTech Inc.: Form D filing
Quest PharmaTech Inc., a pharmaceuticals company in Edmonton, Alberta, Canada, filed a Form D with the SEC in 2015. The latest, on October 29, 2015, reports $1.5 million sold of a $1.5 million offering to 1 investor.
Find out what Quest PharmaTech Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8123 ROPER ROAD NW, Edmonton, Alberta, Canada, T6E 6
- Phone
- 1(780)448-1400
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Alberta, Canada
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1657074
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 29, 2015 | New notice | $1,500,000 | $1,500,000 | $0 | 1 | Oct 13, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Pierre Vermette | Executive Officer | |
| Ian McConnan | Director | |
| Bin Huang | Director | |
| Lorne Meikle | Director | |
| Madi Madiyalakan | Executive Officer | |
| Thomas Woo | Executive Officer | |
| Paul Van Damme | Director | |
| Ragupathy Madiyalakan | Director |
Every Form D from the week of Oct 26, 2015 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Quest PharmaTech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.